IDH1 and astrocytoma (excluding glioblastoma): Jones et al. attempted to model MT and HMP in vitro by establishing IDH1-mutant astrocytoma and IDH1-mutant oligodendroglioma patient-derived cells obtained from surgical tissues of patients at recurrence with chemotherapy-induced hypermutation [15].